Inventor · disambiguated record
Jeongbeob Seo
Also filed as: SEO JEONGBEOB
38 granted patents·14 pending applications·624 citations·filing 2004–2023
98Inventor score
Top patents by PatentIndex Score
52 records- 0198US9493476B2Macrocyclic compounds as trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Nov 15, 2016·46 cites·14 claims
- 0297US9902741B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Feb 27, 2018·22 cites·15 claims
- 0397US9840519B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Dec 12, 2017·21 cites·5 claims
- 0497US9750744B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Sep 5, 2017·21 cites·29 claims
- 0597US9718822B2Macrocyclic compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Aug 1, 2017·22 cites·15 claims
- 0697US8791123B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsALLEN SHELLEY·Filed 2010·Granted Jul 29, 2014·94 cites·61 claims
- 0796US9796724B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 24, 2017·16 cites·30 claims
- 0896US9782415B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Oct 10, 2017·19 cites·30 claims
- 0996US7732616B2Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2006·Granted Jun 8, 2010·35 cites·1 claims
- 1096US7517994B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2005·Granted Apr 14, 2009·36 cites·1 claims
- 1195US9682979B2Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2014·Granted Jun 20, 2017·27 cites·43 claims
- 1295US8933084B2Macrocyclic compounds as Trk kinase inhibitorsANDREWS STEVEN WADE·Filed 2011·Granted Jan 13, 2015·113 cites·52 claims
- 1393US10647730B2Macrocyclic compounds as TRK kinase inhibitorsARRAY BIOPHARMA INC·Filed 2018·Granted May 12, 2020·4 cites·15 claims
- 1492US7893065B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2008·Granted Feb 22, 2011·14 cites·20 claims
- 1591US9701681B2Fused ring heteroaryl compounds and their use as Trk inhibitorsCMG PHARMACEUTICAL CO LTD·Filed 2015·Granted Jul 11, 2017·35 cites·19 claims
- 1691US8211921B2Heterocyclic inhibitors of MEK and methods of useBLAKE JAMES F·Filed 2009·Granted Jul 3, 2012·12 cites·5 claims
- 1789US7598383B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Oct 6, 2009·19 cites·1 claims
- 1888US10251889B2Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Apr 9, 2019·4 cites·18 claims
- 1987US9878997B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2016·Granted Jan 30, 2018·4 cites·10 claims
- 2087US9562055B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsALLEN SHELLEY·Filed 2012·Granted Feb 7, 2017·8 cites·61 claims
- 2186US7723330B2Heterobicyclic pyrazole compounds and methods of useARRAY BIOPHARMA INC·Filed 2007·Granted May 25, 2010·11 cites·58 claims
- 2284US8268852B2Heterocyclic inhibitors of MEK and methods of use thereofBLAKE JAMES F·Filed 2009·Granted Sep 18, 2012·4 cites·14 claims
- 2383US8003662B2Heterobicyclic thiophene compounds and methods of useARRAY BIOPHARMA INC·Filed 2007·Granted Aug 23, 2011·9 cites·9 claims
- 2482US10323022B2Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitorsARRAY BIOPHARMA INC·Filed 2017·Granted Jun 18, 2019·2 cites·26 claims
- 2581US8101639B26-oxo-1,6-dihydropyridine compounds as inhibitors of MEK and methods of use thereofMARLOW ALLISON L·Filed 2009·Granted Jan 24, 2012·4 cites·6 claims
- 2681US7576072B2Heterocyclic inhibitors of MEK and methods of use thereofARRAY BIOPHARMA INC·Filed 2004·Granted Aug 18, 2009·9 cites·18 claims
- 2780US8101611B2Substituted pyridazines inhibitors of MEKMARLOW ALLISON L·Filed 2011·Granted Jan 24, 2012·4 cites·10 claims
- 2877US8394795B2Pyrazole [3, 4-B] pyridine Raf inhibitorsAHRENDT KATERI A·Filed 2009·Granted Mar 12, 2013·5 cites·45 claims
- 2975US8211920B26-oxo-1,6-dihydropyridine derivatives as inhibitors of MEK and methods of use thereofMARLOW ALLISON L·Filed 2008·Granted Jul 3, 2012·1 cites·16 claims
- 3073US2020291026A1Macrocyclic compounds as trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 3170US10758542B2Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Granted Sep 1, 2020·0 cites·11 claims
- 3267US8664230B2Pyridopyrimidine derivatives and use thereofLEE GILNAM·Filed 2012·Granted Mar 4, 2014·3 cites·3 claims
- 3363US2019359597A1Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as trka kinase inhibitorsARRAY BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 3460US2012263679A1Combinations Comprising Heterocyclic Inhibitors of MEK and Methods of Use ThereofMARLOW ALLISON L·Filed 2012·Application pending·0 cites
- 3560US2013018075A1Heterocyclic inhibitors of mek and methods of use thereofMARLOW ALLISON L·Filed 2012·Application pending·0 cites
- 3658US2011178136A1Heterocyclic inhibitors of mek and methods of use thereofARRAY BIOPHARMA INC·Filed 2011·Application pending·0 cites
- 3756US2011288092A1Heterocyclic Inhibitors of MEK and Methods of Use ThereofMARLOW ALLISON L·Filed 2010·Application pending·0 cites
- 3849US12240830B2Fused ring heteroaryl compounds and use thereofBISICHEM CO LTD·Filed 2022·Granted Mar 4, 2025·0 cites·3 claims
- 3948US8299076B2Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamideMARLOW ALLISON L·Filed 2006·Granted Oct 30, 2012·0 cites·24 claims
- 4048US2024083892A1Fused heterocyclic rings as ripk1 inhibitorsBISICHEM CO LTD·Filed 2022·Application pending·0 cites
- 4147US2023219931A1Fused heteroaryl hydroxamates as sting agonistsBISICHEM CO LTD·Filed 2023·Application pending·0 cites
- 4247US2011130406A1Pyrazolo-pyridines as tyrosine kinase inhibitorsARRAY BIOPHARMA INC·Filed 2008·Application pending·0 cites
- 4346US12365695B2Fused ring heteroaryl compounds as RIPK1 inhibitorsBISICHEM CO LTD·Filed 2020·Granted Jul 22, 2025·0 cites·14 claims
- 4445US2014113915A1Novel pyridopyrimidine derivatives and use thereofASAN FOUNDATION·Filed 2013·Application pending·0 cites
- 4544US2011053931A1Quinoline compounds and methods of useGAUDINO JOHN·Filed 2007·Application pending·0 cites
- 4641US2021139435A1Prostaglandin analogs and uses thereofLIFEX BIOLABS INC·Filed 2020·Application pending·0 cites
- 4741US2010256356A1Heterobicyclic pyrazole compounds and methods of useARRAY BIOPHARMA INC·Filed 2010·Application pending·0 cites
- 4839US11932639B2Fused ring heteroaryl compounds as ALK4/5 inhibitorsBISICHEM CO LTD·Filed 2020·Granted Mar 19, 2024·0 cites·5 claims
- 4938US9422298B2Pyridopyrimidine derivatives and use thereofCMG PHARMACEUTICAL CO LTD·Filed 2015·Granted Aug 23, 2016·0 cites·2 claims
- 5034US10494343B2Organic compound, near-infrared fluorescent constant medium containing same, and method for nano-granulating constant mediumCOLLEGE OF MEDICINE POCHON CHA UNIV INDUSTRY—ACADEMIC COOPERATION FOUND·Filed 2016·Granted Dec 3, 2019·0 cites·10 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →